Impact on Prognosis of Lymph Node Micrometastasis and Isolated Tumor Cells in Stage II Colorectal Cancer

다국어 초록 (Multilingual Abstract)

Purpose: Even though the importance of micrometastases (MMS) and isolated tumor cells (ITC) has been brought up by many physicians, its impact on the prognosis in stage II colorectal cancer is uncertain. In this research, we tried to investigate the clinical features of MMS and ITC and to prove any correlation with prognosis.
Methods: The research pool was 124 colorectal cancer patients who underwent a curative resection from April 2005 to November 2009. A total of 2,379 lymph nodes (LNs) were examined, and all retrieved LNs were evaluated by immunohistochemical staining with anti-cytokeratin antibody panel. Clinicopathologic parameters and survival rates were compared based on the presence of MMS or ITC and on the micrometastatic lymph node ratio (mmLNR), which is defined as the number of micrometastatic LNs divided by the number of retrieved LNs.
Results: Out of 124 patients (26.6%) 33 were found to have MMS or ITC. There were no significant differences in clinicopathologic features, such as gender, tumor location and size, depth of invasion, histologic grade, except for age (P = 0.04).
The three-year disease-free survival rate for the MMS or ITC positive group was 85.7%, and that for MMS and ITC negative group was 92.8% (P = 0.209). The three-year disease-free survival rate for the mmLNR > 0.25 group was 73.3%, and that for the mmLNR ≤ 0.25 group was 92.9% (P = 0.03).
Conclusion: The presence of MMS or ITC was not closely correlated to the prognosis. However, mmLNR is thought to be a valuable marker of prognosis in cases of stage II colorectal cancer.

참고문헌 (Reference)

1 Telian SH, "Significance of the lymph node ratio in stage III colon cancer" 15 : 1557-1558, 2008

2 Huvos AG, "Significance of axillary macrome tastases and micrometastases in mammary cancer" 173 : 44-46, 1971

3 Choi HJ, "Proliferating cell nuclear antigen expression and its relationship to malignancy potential in invasive colorectal carcinomas" 40 : 51-59, 1997

4 Bosch Roig CE, "Prognostic value of the detection of lymph node micrometastases in colon cancer" 10 : 572-578, 2008

5 Broll R, "Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study" 40 : 1465-1471, 1997

6 Bilchik AJ, "Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial" 246 : 568-575, 2007

7 Yasuda K, "Pattern of lymph node micrometastasis and prognosis of patients with colorectal cancer" 8 : 300-304, 2001

8 Adell G, "Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes’ B colorectal carcinoma: an immunohistochemical study" 162 : 637-642, 1996

9 Sasaki M, "Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in “node-negative” colorectal cancer" 32 : 758-764, 1997

10 Chen SL, "More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study" 244 : 602-610, 2006

11 Liefers GJ, "Micrometastases and survival in stage II colorectal cancer" 339 : 223-228, 1998

12 Wang J, "Lymph node ratio: role in the staging of node-positive colon cancer" 15 : 1600-1608, 2008

13 Vaccaro CA, "Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons" 52 : 1244-1250, 2009

14 Lee MR, "Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer" 93 : 13-18, 2006

15 Nicastri DG, "Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature" 9 : 563-571, 2007

16 Noura S, "Impact of metastatic lymph node ratio in node-positive colorectal cancer" 2 : 70-77, 2010

17 Verrill C, "Histopathological assessment of lymph nodes in colorectal carcinoma: does triple levelling detect significantly more metastases" 57 : 1165-1167, 2004

18 Brown HG, "Efficacy of manual dissection of lymph nodes in colon cancer resections" 17 : 402-406, 2004

19 Mori M, "Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction" 55 : 3417-3420, 1995

20 Noura S, "Comparative detection of lymph node micrometastases of stage II colorectal cancer by reverse transcriptase polymerase chain reaction and immunohistochemistry" 20 : 4232-4241, 2002

21 박선진, "Clinical Significance of Lymph Node Micrometastasis in Stage I and II Colon Cancer" 대한암학회 40 (40): 75-80, 2008

22 Singletary SE, "Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual" 98 : 2740-2741, 2003

23 National Cancer Center, "Cancer incidence in Korea 1999-2001" National Cancer Center 2005

24 NIH consensus conference, "Adjuvant therapy for patients with colon and rectal cancer" 264 : 1444-1450, 1990

25 Edge, Stephen B, "AJCC cancer staging manual" Springer 2010

26 Chapuis PH, "A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer" 72 : 698-702, 1985